
Bibliography
Acute Kidney Injury and the role of cell-cycle arrest biomarkers
Americas
Europe/Middle East/Africa
Acute kidney injury (AKI) presents an increasing burden worldwide. When not detected at an early stage, AKI can lead to poor patient outcomes and increased healthcare expenditures. Now your clinicians can rapidly assess critically ill patients for risk of moderate to severe AKI.
The NEPHROCHECK® Test is the first commercially available urine test that:
The NEPHROCHECK® Test is available now either built-in our VITROS® automated systems or as a standalone meter to provide clinical laboratories and clinician’s confident results.
Bibliography
Acute Kidney Injury and the role of cell-cycle arrest biomarkers
Visit the NephroCheck® Website to learn more